Krishna Institute of Medical Sciences rises on acquiring 51% stake in Spanv Medisearch Lifescience
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Krishna Institute of Medical Sciences is currently trading at Rs. 1254.15, up by 15.80 points or 1.28% from its previous closing of Rs. 1238.35 on the BSE.
The scrip opened at Rs. 1267.00 and has touched a high and low of Rs. 1272.10 and Rs. 1246.05 respectively. So far 1809 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1532.15 on 04-Jan-2022 and a 52 week low of Rs. 1060.05 on 26-Oct-2021.
Last one week high and low of the scrip stood at Rs. 1300.00 and Rs. 1225.15 respectively. The current market cap of the company is Rs. 10047.89 crore.
The promoters holding in the company stood at 38.84%, while Institutions and Non-Institutions held 31.14% and 30.01% respectively.
Krishna Institute of Medical Sciences has acquired 51% stake in Spanv Medisearch Lifescience (Kingsway Hospitals) and the shares of the Kingsway Hospitals were credited in the Demat A/c of the Company. Earlier, the company had entered into a definitive agreement to acquire a majority stake in Spanv Medisearch Lifescience.
Krishna Institute of Medical Sciences offers a comprehensive range of healthcare services including oncology, cardiac sciences, neurosciences, gastric sciences, orthopaedics, renal sciences, organ transplantation, and mother & child care.
